We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+26.89%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$20.8B
AUM Growth
+$4.96B
(+31%)
Cap. Flow
+$1.12B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
27.86%
Holding
1,558
New
230
Increased
644
Reduced
511
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$93.6M |
| 2 |
Humana
HUM
|
+$63.1M |
| 3 |
Amazon
AMZN
|
+$62.2M |
| 4 |
AbbVie
ABBV
|
+$56M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$85.1M |
| 2 |
TJX Companies
TJX
|
+$63.8M |
| 3 |
Starbucks
SBUX
|
+$58.1M |
| 4 |
Cadence Design Systems
CDNS
|
+$56.8M |
| 5 |
American Tower
AMT
|
+$47.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.15% |
| 2 | Healthcare | 14.99% |
| 3 | Consumer Discretionary | 12.14% |
| 4 | Financials | 11.31% |
| 5 | Communication Services | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUTR
1001
DELISTED
Cutera, Inc.
CUTR
| $671K | ﹤0.01% |
55,164
+42,674
| +342% | +$563K |
|
|
AVID
1002
DELISTED
Avid Technology Inc
AVID
| $670K | ﹤0.01% |
92,100
+43,349
| +89% | +$286K |
|
1003
Brookfield Infrastructure
BIPC
$4.93B
| $669K | ﹤0.01% |
+22,038
| New | +$640K |
|
1004
Stepan Co
SCL
$1.47B
| $665K | ﹤0.01% |
6,848
| – | – |
|
|
ECHO
1005
DELISTED
Echo Global Logistics, Inc.
ECHO
| $664K | ﹤0.01% |
30,710
+13,529
| +79% | +$254K |
|
1006
Zillow
ZG
$7.78B
| $660K | ﹤0.01% |
+11,475
| New | +$565K |
|
|
FBM
1007
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $659K | ﹤0.01% |
42,200
-1,480
| -3% | -$18.7K |
|
1008
QuinStreet
QNST
$1.19B
| $658K | ﹤0.01% |
62,940
+28,890
| +85% | +$279K |
|
1009
Sempra
SRE
$56.5B
| $658K | ﹤0.01% |
11,220
+464
| +4% | +$28.5K |
|
1010
Tandem Diabetes Care
TNDM
$1.62B
| $652K | ﹤0.01% |
6,592
-21,293
| -76% | -$1.7M |
|
1011
Host Hotels & Resorts
HST
$15.6B
| $647K | ﹤0.01% |
+60,005
| New | +$689K |
|
1012
Simmons First National
SFNC
$3.46B
| $646K | ﹤0.01% |
37,783
-2,155
| -5% | -$36.9K |
|
1013
Corcept Therapeutics
CORT
$12B
| $645K | ﹤0.01% |
38,330
+20,600
| +116% | +$289K |
|
1014
Cue Biopharma
CUE
$130M
| $643K | ﹤0.01% |
875
+463
| +112% | +$335K |
|
1015
Fox Class A
FOXA
$27.1B
| $642K | ﹤0.01% |
+23,930
| New | +$646K |
|
|
LAND
1016
Gladstone Land Corp
LAND
$358M
| $642K | ﹤0.01% |
40,502
+18,340
| +83% | +$257K |
|
1017
Miller Industries
MLR
$636M
| $638K | ﹤0.01% |
21,445
+10,204
| +91% | +$290K |
|
|
JNCE
1018
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $638K | ﹤0.01% |
92,420
+39,494
| +75% | +$213K |
|
1019
Ooma
OOMA
$560M
| $636K | ﹤0.01% |
+38,570
| New | +$483K |
|
1020
Atara Biotherapeutics
ATRA
$80.1M
| $635K | ﹤0.01% |
1,744
+1,286
| +281% | +$325K |
|
1021
MeiraGTx Holdings
MGTX
$1.28B
| $629K | ﹤0.01% |
50,233
+28,108
| +127% | +$392K |
|
|
PZN
1022
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $629K | ﹤0.01% |
115,534
+32,407
| +39% | +$151K |
|
|
BPYU
1023
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $628K | ﹤0.01% |
63,090
-36,001
| -36% | -$362K |
|
1024
RBB Bancorp
RBB
$464M
| $627K | ﹤0.01% |
45,950
+19,516
| +74% | +$252K |
|
|
GTS
1025
DELISTED
Triple-S Management Corporation
GTS
| $626K | ﹤0.01% |
32,911
-8,543
| -21% | -$146K |
|
Similar funds
FDCDDQ
TWC
WP
N
PCH
VAI
Los Angeles Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Los Angeles Capital Management held 1,558 positions worth $20.8B, up 31% from $15.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Los Angeles Capital Management deployed $1.12B of net new capital in Q2 2020, opening 230 new positions and adding to 644 existing holdings. Its largest new stake was Workday: 145,773 shares worth $27.3M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Incyte, an estimated $85.1M trimmed.
- Los Angeles Capital Management's largest Q2 2020 buy was Workday: 145,773 shares worth $27.3M.
- Los Angeles Capital Management added most to Meta Platforms (Facebook) in Q2 2020, an estimated $93.6M increase.
- Los Angeles Capital Management's biggest Q2 2020 reduction was Incyte, cutting an estimated $85.1M.
- Los Angeles Capital Management fully exited Raytheon Company in Q2 2020, selling an estimated $4.93M.
- Los Angeles Capital Management's ten largest holdings make up 28% of its $20.8B portfolio in Q2 2020.
- Los Angeles Capital Management opened 230 new positions and closed 111 in Q2 2020.
- Los Angeles Capital Management's portfolio value rose 31% quarter-over-quarter to $20.8B.
Based on Los Angeles Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.